Thrombosis Hemostasis

Embed Size (px)

Citation preview

  • 8/13/2019 Thrombosis Hemostasis

    1/25

    HemostasisA protective process that provides for the rapid generation of alocalized hemostatic plug at the site of a vascular injury - while

    maintaining clot-free blood in normal vessels.Thrombosis

    An inappropriate activation of the hemostatic process leading tothe formation of a clot (thrombus) inside a blood vessels

    during life, obstructing the flow of blood through the circulatorysystem. a pathologic process

    . Thromboembolism is a general term describing boththrombosis and its main complication which isembolisation .they are of variable size and shape ,dependingon causes.

    http://en.wikipedia.org/wiki/Embolismhttp://en.wikipedia.org/wiki/Embolism
  • 8/13/2019 Thrombosis Hemostasis

    2/25

    Thrombosis

  • 8/13/2019 Thrombosis Hemostasis

    3/25

    NORMAL HEMOSTASIS

    After injury and vessel rupture Brief period of vasoconstriction (reflex neurogenic

    mechanism at the arteriole level).

    Attraction of platelets to site of rupture attracted by the

    exposed subendothelial extracellular matrix. Activation of the coagulation system (by tissue factor and

    secreted platelet factors); The activated coagulation systemproduces polymerized fibrin.

    Adherent platelets + aggregated fibrin + entrapped bloodcells form a hemostatic plug.

    Counterregulatory mechanisms are activated to limitpropagation of the hemostatic plug to the injury site.

  • 8/13/2019 Thrombosis Hemostasis

    4/25

    VESSEL WALL

    COLLAGEN TISSUE FACTOR

    CLOTPLATELETS

    INTRINSIC

    PATHWAY EXTRINSIC

    PATHWAY

    COMMON PATHWAY

    Fibrinogen FibrinThrombin

    HEMOSTATIC SYSTEM

  • 8/13/2019 Thrombosis Hemostasis

    5/25

  • 8/13/2019 Thrombosis Hemostasis

    6/25

    Causes

    Classically, thrombosis is caused by abnormalities inone or more of the following ( Virchow 's triad):

    Changes in the composition of the blood favouringplatelet aggregation and fibrin formation(hypercoagulablility).

    Quality of the vessel wall(endothelial damage oraltered endothelial function) eg.thrombi on endocardium , MI ,orulcerated atheromatous plaques in artery walls.bacterial toxin.

    Nature of the blood flow (slowing and perturbation)

    stasis as in polycythemia or aneurysms results in loss of laminar blood flow andallow platelets to adher to the endothelium also allow the local accumulation ofactivated coagulation factor.turbulence causes reduction in endothelial PGI2 and t-PA formation

    http://en.wikipedia.org/wiki/Rudolf_Virchowhttp://en.wikipedia.org/wiki/Rudolf_Virchow
  • 8/13/2019 Thrombosis Hemostasis

    7/25

    THROMBOSIS Virchows TRIANGLE

    ENDOTHELIALINJURY

    ABNORMAL FLOW(NON-LAMINAR)

    HYPER-COAGULATION

  • 8/13/2019 Thrombosis Hemostasis

    8/25

    ENDOTHELIAL INJURY any perturbation in the dynamic balance

    of the pro- and antithrombotic effects ofendothelium, not only physical damage

  • 8/13/2019 Thrombosis Hemostasis

    9/25

    ENDOTHELIUM ANTI-Platelet PROPERTIES

    Protection from the subendothelial ECM Degrades ADP (inhib. Aggregation)

    ANTI-Coagulant PROPERTIES Membrane HEPARIN-like molecules Makes THROMBOMODULIN Protein-C TISSUE FACTOR PATHWAY INHIBITOR

    FIBRINOLYTIC PROPERTIES (TPA)PROTHROMBOTIC PROPERTIES

    Makes vWF , which bindsPlats CollMakes TISSUE FACTOR (with platsMakes Plasmino en inhibitors

  • 8/13/2019 Thrombosis Hemostasis

    10/25

    ABNORMAL FLOW

    NON-LAMINAR FLOW TURBULENCE EDDIES STASIS DISRUPTED ENDOTHELIUM

    ALL of these factors may bring plateletsinto contact with endothelium and/orECF

  • 8/13/2019 Thrombosis Hemostasis

    11/25

    1 HYPERCOAGULABILITY(INHERITED)

    COMMONEST: Factor V and Prothrombin defects

    Common: Mutation in prothrombin gene,Mutation in methyltetrahydrofolate gene Rare: Antithrombin III deficiency, Protein C

    deficiency, Protein S deficiency Very rare: Fibrinolysis defects

  • 8/13/2019 Thrombosis Hemostasis

    12/25

    2 HYPERCOAGULABILITY (ACQUIRED)

    Prolonged bed rest or immobilization

    Myocardial infarction

    Atrial fibrillation Tissue damage (surgery, fracture, burns) Cancer (TROUSSEAU syndrome, i.e., migratory thrombophlebitis) Prosthetic cardiac valves Disseminated intravascular coagulation Heparin-induced thrombocytopenia Antiphospholipid antibody syndrome (lupus anticoagulant syndrome)

    Lower risk for thrombosis: Cardiomyopathy Nephrotic syndrome Hyperestrogenic states (pregnancy) Oral contraceptive use

    Sickle cell anemia Smokin Obesit

  • 8/13/2019 Thrombosis Hemostasis

    13/25

    ARTERIAL/CARDIAC THROMBI ACUTE MYOCARDIAL INFARCTION = OLD

    ATHEROSCLEROSIS + FRESH THROMBOSIS ARTERIAL THROMBI also may send fragments

    DOWNSTREAM, but these fragments may

    contain flecks of PLAQUE also LODGING is PROPORTIONAL to the % of

    cardiac output the organ receives, i.e., brain,kidneys, spleen, legs, or the diameter of thedownstream vessel

  • 8/13/2019 Thrombosis Hemostasis

    14/25

    Atherosclerosis is characterized by intimal lesions calledatheromas , or atheromatous or fibrofatty plaques , that protrudeinto and obstruct vascular lumina, weaken the underlying media,

    and may undergo serious complications.

    http://www.robbinspathology.com/content/lightbox.cfm?action=add&ImgID=F011007&ImgBody=graphics/S01871-011-f007.jpg&ID=iBoxhttp://www.robbinspathology.com/content/lightbox.cfm?action=add&ImgID=F011007&ImgBody=graphics/S01871-011-f007.jpg&ID=iBox
  • 8/13/2019 Thrombosis Hemostasis

    15/25

    15

    ATHEROSCLEROTIC PLAQUE

    NORMAL ARTERY ATHEROSCLEROTICPLAQUE

  • 8/13/2019 Thrombosis Hemostasis

    16/25

    60% Narrowing of Coronary Artery

  • 8/13/2019 Thrombosis Hemostasis

    17/25

    90% Blockage of Coronary Artery

    calcified arearemaining lumen

  • 8/13/2019 Thrombosis Hemostasis

    18/25

    Thrombus Causing MI

    needle -like white spots are cholesterol crystals

  • 8/13/2019 Thrombosis Hemostasis

    19/25

    Atherosclerotic Plaque Histology

    cholesterol crystal (cleft) foam cells

  • 8/13/2019 Thrombosis Hemostasis

    20/25

    Myocardial Infarction Histology

    necrosed muscle cells red blood cells

  • 8/13/2019 Thrombosis Hemostasis

    21/25

    Myocardial Infarction Histology

    normal muscle cells remaining macrophages and the

    beginnings of scar tissue

  • 8/13/2019 Thrombosis Hemostasis

    22/25

    Type of thrombi (appearance) White thrombi (pale) Arterial: blood flow

    rapid,firm aggregate of plt, fibrin, fewWBC/RBC Red thrombi :venous:; blood flow slower,soft

    dark red: RBC trapped in fibrin mesh Mixed: pale and red(laminated appearance)

    ADHERENCE TO VESSEL WALLHEART (MURAL)

    ARTERY (OCCLUSIVE/INFARCT)VEINOBSTRUCTIVE vs. NON-OBSTRUCTIVERED, YELLOW, GREY/WHITEACUTE, ORGANIZING, OLD

  • 8/13/2019 Thrombosis Hemostasis

    23/25

    Sequels of Block

    Collateral circulation: Ischemia,

    Infarction, Gangrene Haemorrhage

  • 8/13/2019 Thrombosis Hemostasis

    24/25

    Fat e o f t h r o m b u s Spread (propagation) Accumulation of more

    platelets and fibrin, becoming larger

    Detachment: to form embolus(embolization) Removal (dissolution)

    1. shrinkage of thrombus by contraction2.lysis by plasmin and proteolytic enz

    3.organization-digestion by macrophageand ingrowth of fibrovascular ts.

    4.endothelialization,incorporation into vesselwall by growth of endothelum over its

    surface Organization and recanalizationthrombi may induce inflamation and fibrosis(organization)and

    may eventually recanalized or they may be incorporatedinto a thickened vascular wall.

  • 8/13/2019 Thrombosis Hemostasis

    25/25

    SCHEMATIC ON THE FATE OF A THROMBUS